ZEBINIX 800 mg, tablet 30 tablets
Active ingredients: ESLICARBAZÉPINE (ACÉTATE D')
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZEBINIX 800 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- BIAL - PORTELA & CA (PORTUGAL)
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Epilepsie, chez les adultes, dans certains cas. ; JOURNAL OFFICIEL ; 01/03/12
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Apr 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68829121CIP73973499CIP133400939734996Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ESLICARBAZÉPINE (ACÉTATE D')comprimé | 800 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: ESLICARBAZEPINE (ACETATE D') 800 mg - ZEBINIX 800 mg, comprimé